Thursday, January 27, 2022
wellness India Expo
Home Tags SARS

Tag: SARS

Bharat Biotech’s COVAXIN Phase 3 results show interim clinical efficacy of...

Data from 25,800 participants that received the COVAXIN vaccine or placebo in a 1:1 ratio showed that the vaccine candidate was well-tolerated. It demonstrated 81% interim efficacy in preventing COVID-19 after the second dose....................

Shycocan, world’s first virus attenuation device developed in Bengaluru

Inventors claim it to be effective in securing indoor spaces from the spread of not only the Coronavirus family which cause diseases like pneumonia, ARDS, SARS, MERS, COVID-19.....................

Roche Diagnostics launches test to measure antibody levels against SARS-CoV-2

The test targets antibodies against the spike protein and plays an important part in characterizing a vaccine-induced immune response..........................

IAVI, Merck & Serum Institute join forces to develop monoclonal antibodies...

Partners aim to provide potent neutralizing antibodies for COVID-19 pandemic response. The approach is complementary to future COVID-19 vaccines.........................

GeneStore launches rRT PCR Covid testing kit at Rs 199, claims...

GeneStore Detection Expert priced at INR 199, detects SARS CoV2 in under one hour delivering a 100% accurate result with exceptional sensitivity and specificity....................

Healthcare professionals come together as part of “Doctors for One Health”...

Over a hundred healthcare professionals have joined hands with the Federation of Indian Animal Protection Organisations (FIAPO) under the “Doctors for One Health” initiative to address the rapidly growing challenges for healthcare systems.......................

Krishgen Biosystems releases two latest Assays for SARS-CoV-2

Mumbai-based biotech company, Krishgen Biosystems has released two latest Assays for SARS-CoV-2 (Covid-19) Research - GENLISA surrogate Virus Neutralization Test ELISA and the GENLISA Inhibitor Screening ELISA..............

Bharat Biotech’s COVID-19 vaccine ‘COVAXIN’ gets DCGI nod, human trials to...

Human trials of India’s first indigenous experimental vaccine against COVID-19, COVAXIN, developed by Bharat Biotech is set to begin across India in July........................

Sun Pharma initiates Phase II clinical trial of first phytopharma drug...

Clinical trial of the drug that has shown anti-SARS-CoV-2 effects in in-vitro studies conducted in collaboration with ICGEB will be conducted across 12 centers in India in 210 patients; results expected by October 2020.............................

Syngene partners HiMedia Labs to manufacture ELISA test kits for COVID-19

Syngene has indigenously developed an anti-COV-2 IgG ELISA (Enzyme-Linked Immunosorbent Assay) at its research facility in Bengaluru. Having partnered with Hi-Media, the commercialized kit will be launched under the brand name ELISafe 19...............